Monday, June 29, 2026 · Covering: Fri–Mon this weekend
TL;DR
The weekend brought three deals worth watching: AkzoNobel and Axalta set a shareholder vote for August 5 on their $25B all-stock merger of equals that would create the world's largest coatings company, Select Medical's $3.9B take-private by Welsh Carson and its own founders won stockholder approval, and the Electronic Arts $55B LBO — the largest in history — is expected to close tomorrow (June 30). On top of that, Alphabet officially joins the Dow Jones Industrial Average today, replacing Verizon, while Apple and Microsoft spooked markets late last week by raising device prices due to AI-driven chip cost inflation — a signal that the "picks and shovels" tariff and memory chip crunch is starting to hit consumer products.
TOP 3 DEALS
DEAL 01
Industrials / Specialty Chemicals
DEAL SIZE (EV)$25B combined EV · 0.6539 AKZO per AXTA share + €2.5B pre-close dividend
SHAREHOLDER VOTEAugust 5, 2026 (close expected late 2026 / early 2027)
AKZONOBEL ADVISORSMorgan Stanley (lead) + Lazard (supervisory board); NautaDutilh (legal)
AXALTA ADVISORSEvercore (exclusive financial; $45M fee); Skadden (legal)
AkzoNobel (Dutch, maker of Dulux paints and industrial coatings) and Axalta (US, auto refinishing and industrial coatings) are combining in an all-stock, no-premium merger of equals that would create a coatings giant with $17B in combined revenue — leapfrogging Sherwin-Williams and PPG to become the world's largest coatings company. AkzoNobel is also paying a €2.5B pre-close special dividend to its own shareholders to balance the exchange ratio, which is a neat piece of transaction engineering.
Why it matters for recruiting: Mergers of equals are structurally different from acquisitions — there's no "premium" to justify, which changes how fairness opinions work. Evercore's $45M contingent fee (disclosed in the proxy) is a window into how advisor compensation scales with deal size and complexity. The €2.5B special dividend is an example of "value transfer" in cross-border M&E where currency, tax, and shareholder base differences need balancing. Both companies have faced activist pressure for years; understand why consolidation is the strategic answer when organic growth stalls. Yahoo Finance ↗
DEAL 02
Healthcare Services
DEAL SIZE (EV)~$3.9B · $16.50/share all-cash · 9.2x EBITDA
STOCKHOLDER APPROVALJune 26, 2026 (close expected mid-2026)
BUYER ADVISORS (CONSORTIUM / WCAS)Wells Fargo + J.P. Morgan (consortium); Barclays (WCAS); Cravath + Ropes & Gray (legal)
SELLER ADVISORS (SPECIAL COMMITTEE)Goldman Sachs (exclusive); Skadden (legal); Dechert (company legal)
Select Medical operates a network of specialty hospitals — critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehab centers — across the US. The company's own co-founders (Executive Chairman Robert Ortenzio and Senior EVP Martin Jackson), who still own a significant stake, teamed with healthcare-specialist PE firm Welsh Carson Anderson & Stowe to take the company private at $16.50 per share. Shareholders approved the deal last Thursday with an overwhelming vote; it's now awaiting final regulatory sign-off before closing.
Why it matters for recruiting: This is a textbook founder-led take-private: insiders know the business best and believe the public market is chronically undervaluing it (9.2x EBITDA is low for a healthcare services asset). Welsh Carson's role is interesting — they're healthcare-only PE, which means they bring operational expertise, not just capital. Note the three-advisor structure on the buy side: Wells Fargo + JPM for the full consortium, Barclays separately for WCAS. In deals where one PE firm is "lead" in a consortium, each member often hires their own advisor for fee-splitting and independence reasons. Scope Research ↗
DEAL 03
LBO / Leveraged Finance
DEAL SIZE (EV)~$55B · $210/share all-cash · 25% premium
EXPECTED CLOSEJune 30, 2026 (announced February 2026)
BUYERSSaudi PIF + Silver Lake + Affinity Partners (Jared Kushner)
DEBT FINANCING~$20B committed by J.P. Morgan — largest LBO debt package ever
The Electronic Arts buyout closes tomorrow, officially becoming the largest leveraged buyout in corporate history — surpassing the $32B TXU Energy deal from 2007. Saudi Arabia's Public Investment Fund (essentially the sovereign wealth fund doing PE), Silver Lake (tech-focused buyout firm), and Affinity Partners (Jared Kushner's fund) are the equity consortium, putting up roughly $36B in equity against $20B in JPMorgan-committed debt. EA makes games like Madden, FIFA (now EA Sports FC), Apex Legends, and The Sims.
Why it matters for recruiting: This is a must-know deal for lev fin and generalist M&A interviews in 2026. Key mechanics to understand: (1) Leverage ratio — $20B debt on a ~$55B deal is roughly 36% leverage, conservative for an LBO, reflecting debt market caution at current rates; (2) Sovereign wealth as PE — PIF is increasingly acting like a PE co-investor, bypassing fund structures for direct co-investment at scale; (3) Content IP as collateral — lenders are comfortable with EA's recurring revenue from live-service games (FIFA Ultimate Team alone generates ~$2B/year); (4) Why go private? — EA was undervalued by public markets relative to its IP library and live-service ARPU growth. Angel Investors Network ↗
SECTOR SIGNAL
DEFENSE / AEROSPACE
Honeywell completed its long-planned aerospace spin-off this weekend. The parent company — renamed Honeywell Technologies — retains its remaining businesses and stays in the Dow Jones Industrial Average, while Honeywell Aerospace becomes an independent public company. Watch for M&A activity in the standalone aero entity as it builds out its defense electronics and engine components portfolio. StockTitan ↗
TECH / TMT
Alphabet joined the Dow Jones Industrial Average today, replacing Verizon after 22 years — the first time all five US mega-cap tech companies (Nvidia, Amazon, Apple, Microsoft, Alphabet) hold Dow seats simultaneously. Separately, Apple raised MacBook and iPad prices by up to $300 and Microsoft raised Xbox prices by up to $150, both blaming AI-driven memory chip cost inflation. Axios ↗
INDUSTRIALS
The AkzoNobel/Axalta merger (Deal 1) is the week's industrials headline. Beyond coatings, AI compute build-out continues to drive M&A in power infrastructure and data center cooling — PwC's mid-year industrials outlook flags this as the dominant deal driver for H2 2026. PwC ↗
HEALTHCARE / OTHER
Select Medical's take-private (Deal 2) is the weekend's healthcare headline. More broadly, specialty hospital and post-acute care services remain an attractive PE target because reimbursement is relatively protected vs. acute care, and operational improvement (length-of-stay optimization, staffing ratios) creates a clear value creation playbook for sponsors.Becker's ↗
M&A / LEVERAGED FINANCE
EA's $55B LBO closing tomorrow (Deal 3) caps a remarkable fortnight for leveraged finance — coming right after Clearwater Analytics' $8.4B take-private closed last Wednesday. The two deals combined put over $63B of take-private transaction value across the tape in one week. Key lev fin signal: JPMorgan committed $20B in debt for EA at a time when the Fed is threatening rate hikes and PCE is running at 3.6%. That implies strong confidence in EA's free cash flow durability — lenders care about debt serviceability, not just enterprise value. CreditSights ↗
MARKET TONE
Alphabet enters the Dow today; tech dominance now official. All five US mega-cap tech companies now hold seats in the 30-stock DJIA — a symbolic milestone that reflects how much the US economy has reoriented around tech. Verizon exits after 22 years. Yahoo Finance ↗
Apple and Microsoft raise prices; AI chip crunch hits consumers. Apple raised MacBook and iPad prices by $200–$300, Microsoft raised Xbox prices $100–$150, both citing AI-driven memory chip cost inflation. This is the first clear pass-through of semiconductor supply squeeze to retail — watch for margins in consumer tech to compress in H2. Bloomberg ↗
Mag 7 under pressure; Dow near record 52,100. The Magnificent 7 sold off Friday on Apple and Microsoft price hike news and AI cost concerns. Despite the tech drag, the Dow closed near 52,100 — a record — as rotation into value and defensive names continued. TheStreet ↗
Key data due tomorrow: consumer confidence, JOLTS, Nike/Constellation earnings. June 30 is a data-heavy day — June consumer confidence, May JOLTS (job openings), and major consumer earnings will test whether the hawkish Fed and elevated inflation are denting spending. Schwab ↗
No rate cuts until 2027; lev fin markets adapt. BofA's latest note pushes rate cut expectations to mid-to-late 2027. Yet LBO deal flow is running above 2025 levels, suggesting PE firms are structuring around higher rates rather than waiting — using more equity, fewer covenant-lite structures, and tighter debt packages. BofA ↗
INTERVIEW ANGLE
TOPIC: MERGERS OF EQUALS — WHY NO PREMIUM, AND WHAT MAKES THEM HARD
The AkzoNobel/Axalta deal is one of the rare true mergers of equals (MOE) — a structure that sounds simple but is actually one of the most complicated deal types to execute. Unlike a standard acquisition where the buyer pays a premium over market, an MOE combines two public companies at (roughly) an exchange ratio that values both at fair market. Here's how to discuss it in an interview.
Why is there no premium? In an MOE, neither party is officially the "acquirer" — both sides argue their shareholders are getting a fair exchange of ownership in a stronger combined company. A premium would imply one side "won," creating political and governance problems. Instead, the deal's value comes entirely from synergies.
How do you value an MOE without a premium? You run a contribution analysis (what % of combined revenue, EBITDA, and free cash flow each side contributes) and check whether the exchange ratio reflects those contributions fairly. If AXTA contributes 40% of combined EBITDA but gets 38% ownership, its shareholders might vote no.
What's the €2.5B pre-close dividend? AkzoNobel is paying its own shareholders a special dividend before close to compensate for the fact that Axalta shareholders are receiving shares in the combined company — it's a way to rebalance value when the exchange ratio alone doesn't create symmetry.
Why do MOEs fail so often? Governance. Who runs the company? What's the board split? Which headquarters stays? MOEs often stall or blow up in integration because neither side accepts a subordinate role. Evercore's $45M fairness opinion fee reflects months of negotiation to get both boards to sign off.
Why is Evercore's fee contingent on close? Standard practice — advisors are paid mostly on success to align incentives. The $45M total fee (vs. ~$3M on opinion delivery) means Evercore has a strong financial interest in getting this deal done.
How to bring it up: "The AkzoNobel/Axalta merger is interesting to me because MOEs rarely get done — the governance negotiation is usually as hard as the financial modeling. I've been thinking through how a contribution analysis differs from a standard DCF or LBO in that context. Is that a deal type your group advises on often?"